• WATSON PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: WPI

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.000 Hold 15
    30 Days Ago 3.000 Hold 16
    60 Days Ago 3.000 Hold 16
    90 Days Ago 2.938 Hold 16
    120 Days Ago 2.941 Hold 17

  • Analyst Ratings: WPI

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Roth Capital — Buy 02/25/2008 38.00
    Lehman Brothers — Equal-weight 02/21/2008 33.00
    WR Hambrecht Hold Buy 02/19/2008 —
    Banc of America Sec — Neutral 12/18/2007 31.00
    Roth Capital Hold Buy 09/28/2007 39.00
    Roth Capital — Hold 08/03/2007 34.50
    UBS Neutral Buy 05/02/2007 37.00
    Roth Capital — Hold 05/02/2007 31.00
    Goldman Sachs Sell Neutral 03/26/2007 —
    UBS — Neutral 03/23/2007 27.00
    Roth Capital Buy Hold 02/28/2007 30.00
    Roth Capital — Buy 11/08/2006 30.00
    FTN Midwest — Buy 10/17/2006 —
    Prudential — Underweight 08/07/2006 23.00
    JP Morgan — Underweight 07/19/2006 —
    Credit Suisse — Neutral 06/29/2006 —
    Roth Capital — Buy 06/15/2006 31.00
    Leerink Swann — Outperform 03/02/2006 —
    UBS Reduce Neutral 02/24/2006 30.50
    Prudential — Underweight 02/17/2006 28.00
    Morgan Stanley Equal-weight Underweight 01/11/2006 —
    UBS Neutral Reduce 09/02/2005 —
    Banc of America Sec — Neutral 08/05/2005 32.00
    WR Hambrecht — Hold 07/22/2005 —
    Susquehanna Financial — Net Negative 07/21/2005 —
    CE Unterberg Towbin Market Perform — 05/26/2005 —
    UBS — Neutral 05/26/2005 39.50
    Lehman Brothers Overweight Equal-weight 03/28/2005 33.00
    CIBC Wrld Mkts — Sector Underperform 02/11/2005 32.00
    Prudential — Underweight 02/10/2005 26.00
    Next